本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Pasithea Therapeutics Corp.

0.8700
+0.03904.69%
盘后0.87000.00000.00%18:36 EDT
成交量:103.61万
成交额:88.58万
市值:568.05万
市盈率:-0.07
高:0.9000
开:0.8850
低:0.8223
收:0.8310
数据加载中...
2022/06/16

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/06/10

重要事件披露

8-K - Current report
2022/06/01

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2022/05/16

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/12

[修订]年度报告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/30

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/03

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/01

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/12/21

重要事件披露

8-K - Current report
2021/12/20

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/12/14

SEC问询函

CORRESP [Cover] - Correspondence
2021/12/09

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2021/11/29

重要事件披露

8-K - Current report
2021/11/18

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/11/04

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/09/22

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/09/13

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/09/10

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/09/10

SEC问询函

CORRESP [Cover] - Correspondence